CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Crystal Structure of the Tsh Receptor (Tshr) Bound to a Blocking-Type Tshr Autoantibody.

Crystal Structure of the Tsh Receptor in Complex with a Thyroid-Stimulating Autoantibody

Monoclonal Autoantibodies to the Tsh Receptor, One with Stimulating Activity and One with Blocking Activity, Obtained from the Same Blood Sample.

Tsh Receptor - Autoantibody Interactions.

Human Monoclonal Thyroid Stimulating Autoantibody

Characteristics of a Human Monoclonal Autoantibody to the Thyrotropin Receptor: Sequence Structure and Function

Thyroid Stimulating Autoantibody M22 Mimics Tsh Binding to the Tsh Receptor Leucine Rich Domain: A Comparative Structural Study of Protein-Protein Interactions.

Effects of Tsh Receptor Mutations on Binding and Biological Activity of Monoclonal Antibodies and Tsh

Molecular Interactions between the Tsh Receptor and a Thyroid-Stimulating Monoclonal Autoantibody

Fsh and Tsh Binding to Their Respective Receptors: Similarities, Differences and Implication for Glycoprotein Hormone Specificity

THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN
FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229

THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN
FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213

LEUCINE RICH REPEAT DOMAIN, RESIDUES 22-260

THYROID-STIMULATING HORMONE RECEPTOR, TSH-R

EVQLVQSGAEVKKPGQSLKISCKASGYSLTDNWIGWVRQKPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSINTAY
LQWSSLKASDTAIYYCVGLDWNYNPLRYWGPGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSW
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS

QSVLTQPPSVSAAPGQKVTISCSGSSSDIGSNYVSWYQQFPGTAPKLLIYDNNKRPSAIPDRFSGSKSGTSATLGITGLQ
TGDEADYYCGTWDSRLGIAVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLVSDFYPGAVTVAWKADGSPVK
VGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCRVTHEGSTVEKTVAPTE

MGCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS
KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT
LKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTL

16% PEG 3350, 0.2 M SODIUM MALONATE PH 5.

THEORETICAL MODEL OF THE LIGAND-BINDING REGION OF AGLYCOPROTEIN HORMONE RECEPTOR

HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES REFINED INDIVIDUALLY.

SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX, GPCR, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR-AUTOANTIBODY COMPLEX